Imperial College London
Portrait Picture

Peter Openshaw - Professor of Experimental Medicine

Faculty of Medicine, National Heart & Lung Institute

Proconsul, Professor of Experimental Medicine
 
 
 
//

Contact

 

+44 (0)20 7594 3854p.openshaw Website CV

 
 
//

Assistant

 

Ms Gale Lewis +44 (0)20 7594 0944

 
//

Location

 

353Norfolk PlaceSt Mary's Campus

//

Summary

 

Publications

Citation

BibTex format

@article{Schuijs:2016:10.1371/journal.pone.0161885,
author = {Schuijs, MJ and Hartmann, S and Selkirk, ME and Roberts, LB and Openshaw, PJ and Schnoeller, C},
doi = {10.1371/journal.pone.0161885},
journal = {PLOS One},
title = {The Helminth-Derived Immunomodulator AvCystatin Reduces Virus Enhanced Inflammation by Induction of Regulatory IL-10+ T Cells.},
url = {http://dx.doi.org/10.1371/journal.pone.0161885},
volume = {11},
year = {2016}
}
Download

RIS format (EndNote, RefMan)

TY  - JOUR
AB  - Respiratory Syncytial Virus (RSV) is a major pathogen causing low respiratory tract disease (bronchiolitis), primarily in infants. Helminthic infections may alter host immune responses to both helminths and to unrelated immune triggers. For example, we have previously shown that filarial cystatin (AvCystatin/Av17) ameliorates allergic airway inflammation. However, helminthic immunomodulators have so far not been tested in virus-induced disease. We now report that AvCystatin prevents Th2-based immunopathology in vaccine-enhanced RSV lung inflammation, a murine model for bronchiolitis. AvCystatin ablated eosinophil influx, reducing both weight loss and neutrophil recruitment without impairing anti-viral immune responses. AvCystatin also protected mice from excessive inflammation following primary RSV infection, significantly reducing neutrophil influx and cytokine production in the airways. Interestingly, we found that AvCystatin induced an influx of CD4+ FoxP3+ interleukin-10-producing T cells in the airway and lungs, correlating with immunoprotection, and the corresponding cells could also be induced by adoptive transfer of AvCystatin-primed F4/80+ macrophages. Thus, AvCystatin ameliorates enhanced RSV pathology without increasing susceptibility to, or persistence of, viral infection and warrants further investigation as a possible therapy for virus-induced airway disease.
AU  - Schuijs,MJ
AU  - Hartmann,S
AU  - Selkirk,ME
AU  - Roberts,LB
AU  - Openshaw,PJ
AU  - Schnoeller,C
DO  - 10.1371/journal.pone.0161885
PY  - 2016///
SN  - 1932-6203
TI  - The Helminth-Derived Immunomodulator AvCystatin Reduces Virus Enhanced Inflammation by Induction of Regulatory IL-10+ T Cells.
T2  - PLOS One
UR  - http://dx.doi.org/10.1371/journal.pone.0161885
UR  - http://hdl.handle.net/10044/1/39591
VL  - 11
ER  -
Download